M. Suzanne Stratton - Concepedia

Author

M. Suzanne Stratton

Also Known As

M S Stratton, M Stratton, M Suzanne Stratton, M. S. Stratton, M. Stratton, M. Suzanne Stratton, M.S. Stratton, M.Suzanne Stratton, Mimi Suzanne Stratton

Publications

870

Citations

H-Index

Concepts

All Affiliations

University of Arizona Roswell Park Comprehensive Cancer Center University at Buffalo, State University of New York Medical University of South Carolina

About

M. Suzanne Stratton is an author at University of Arizona specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	466
2	Clinical Nutrition	2	2	72
3	Health Sciences	1	1	51
4	Public Health	1	1	44
5	Diabetes	1	1	21

M. Suzanne Stratton

Publications

824

Citations

H-Index

Page 1

	Year	Citations
A report of high-dose selenium supplementation: response and toxicities Mary E. Reid, M. Suzanne Stratton, Anna J. Lillico, Journal of Trace Elements in Medicine and Biology NutritionHigh-dose Selenium SupplementationDietary ExposureSelenium DeficiencyMedicine	2004	226
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high‐risk for prostate cancer Amit M. Algotar, M. Suzanne Stratton, Frederick R. Ahmann, The Prostate	2012	102
A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin Elaine L. Jacobson, Hyun-Tae Kim, Moonsun Kim, Experimental Dermatology	2007	61
Oral Selenium Supplementation Has No Effect on Prostate-Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer M. Suzanne Stratton, Amit M. Algotar, James Ranger‐Moore, Cancer Prevention Research NutritionChemoprevention StrategyBaseline SeleniumCancer TrialProstate-specific Antigen Velocity	2010	51
Selenium and selenomethionine levels in prostate cancer patients David Nyman, M. Suzanne Stratton, Michael J. Kopplin, Cancer Detection and Prevention UrologySelenium DeficiencyMedicineProstate Cancer PatientsProstatic Disease	2004	50
Fibroblast Growth Factor-1 Induced Promatrilysin Expression Through the Activation of Extracellular-regulated Kinases and STAT3 Thirupandiyur S. Udayakumar, M. Suzanne Stratton, Raymond B. Nagle, Neoplasia	2002	48
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the ‘Watchful Waiting’ Study M. Suzanne Stratton, Marvin Reid, G. Schwartzberg, Anti-Cancer Drugs	2003	48
Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study M. Suzanne Stratton, Marvin Reid, G. Schwartzberg, Anti-Cancer Drugs UrologyCancer RiskCancer EpidemiologySelenium DeficiencyGenitourinary Cancer	2003	44
Prostatic adenocarcinoma evolving into carcinoid: selective effect of hormonal treatment? M. Suzanne Stratton, David J. Evans, Irvin A. Lampert Journal of Clinical Pathology UrologyEndocrine-related CancerProstatic AdenocarcinomaMedicineGynecology	1986	35
Current application of selective COX-2 inhibitors in cancer prevention and treatment. M. Suzanne Stratton, David S. Alberts PubMed Current ApplicationChemoprevention StrategyPathologyPharmacotherapyAnti-cancer Agent	2002	27

Page 1